Omaha World-Herald reports that Nebraska cultivators approved under the state medical cannabis rollout still lack seed stock as they near planting. This technical explainer outlines the practical options, compliance considerations and genetic-supply risks that licensed operators should weigh when a programme reaches the planting phase but genetics have not arrived.

Hyde's Hail Mary has entered New York through a statewide distribution partnership with MOOV Distribution, offering a clear example of how brand-scale players are using distribution agreements to access regulated state markets. This piece explains the commercial context, what the move means for retailers and competitors, and the practical questions the industry should watch next.

MJBizDaily’s recent piece argues that the cannabis industry must give genetics a strategic role beyond marketing. For breeders, seedbanks and commercial growers that means clear provenance, investment in breeding and data, and active stewardship to protect diversity, IP and supply resilience. This editorial explains what the argument means in practical terms for professionals and where the industry will need attention next.